Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Polynovo ( (AU:PNV) ) has provided an update.
PolyNovo Limited has reported a significant increase in cash holdings and operational cash flow for FY25, with a notable rise in group sales by 28.9% compared to the previous year. The company anticipates continued profit momentum into FY26, driven by strong sales growth in the U.S. and other international markets, alongside strategic investments in new manufacturing and R&D facilities.
The most recent analyst rating on (AU:PNV) stock is a Buy with a A$2.85 price target. To see the full list of analyst forecasts on Polynovo stock, see the AU:PNV Stock Forecast page.
More about Polynovo
PolyNovo Limited operates in the medical technology industry, focusing on the development and commercialization of innovative medical devices. The company is known for its biodegradable polymer technology, primarily targeting markets in Australia, New Zealand, the UK, and the U.S.
Average Trading Volume: 2,068,541
Technical Sentiment Signal: Sell
Current Market Cap: A$891.2M
For detailed information about PNV stock, go to TipRanks’ Stock Analysis page.